Effect of retinyl acetate on transglutaminase 2 activity in carcinogen treated rat liver

References

• Aydin O, Akyuz F, Tekin N, Burukoglu D, Ozden H, Ustuner MC, Degirmenci I (2014) The role of retinyl acetate in chemoprevention. J. Food Nutr. Res. 2: 9–16.
   Google Scholar
• Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72: 248.
   PubMed Web of Science ®Google Scholar
• Budillon A, Carbone C, Di Gennaro E (2013) Tissue transglutaminase: a new target to reverse cancer drug resistance. Amino Acids 44: 63–72.
   PubMed Web of Science ®Google Scholar
• Bukhari MH, Qureshi SS, Niazi S, Asef M, Naheed M, Khan SA, Chaudhry NA, Tayyab M, Hasan M (2007) Chemotherapeutic/chemopreventive role of retinoids in chemically induced skin carcinogenesis in albino mice. Int. J. Dermatol. 46: 1160–1165.
   PubMed Web of Science ®Google Scholar
• Cho SY, Lee JH, Bae HD, Jeong EM, Jang GY, Kim CW, Shin DM, Jeon JH, Kim IG (2010) Transglutaminase 2 inhibits apoptosis induced by calcium- overload through down-regulation of Bax. Exp. Mol. Med. 42: 639–650.
   PubMed Web of Science ®Google Scholar
• Czekaj P (2004) Molecular and cellular mechanisms of chemically induced hepatocarcinogenesis. Pol. J. Env. Stud. 13: 477–486.
   Web of Science ®Google Scholar
• Czepiel J, Biesiada G, Gajda M, Szczepanski W, Szypuła K, Dabrowski Z, Mach T (2010) The effect of TCDD dioxin on the rat liver in biochemical and histological assessment. Fol. Biol. (Krakow) 58: 85–90.
   PubMed Web of Science ®Google Scholar
• Elli L, Bergamini CM, Bardella MT, Schuppan D (2009) Transglutaminases in inflammation and fibrosis of the gastrointestinal tract and the liver. Dig. Liver Dis. 41: 541–550.
   PubMedGoogle Scholar
• Fletcher N, Giese N, Schmidt C, Stern N, Lind PM, Viluksela M, Tuomisto JT, Tuomisto J, Nau H, Hakansson H (2005) Altered retinoid metabolism in female Long-Evans and Han/Wistar rats following long term 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) treatment. Toxicol. Sci. 86: 264–272.
   PubMed Web of Science ®Google Scholar
• Folk JE, Chung SI (1985) Transglutaminases. Methods Enzymol. 113: 358–375.
   PubMed Web of Science ®Google Scholar
• Guengerich FP (2000) Metabolism of chemical carcinogens. Carcinogenesis 21: 345–351.
   PubMed Web of Science ®Google Scholar
• Hardisty JF, Brix AE (2005) Comparative hepatic toxicity: prechronic/chronic liver toxicity in rodents. Toxicol. Pathol. 33: 35–40.
   PubMed Web of Science ®Google Scholar
• Jung JE, Moon JY, Ghil SH, Yoo BS (2009) 2, 3, 7, 8-Tetrachlorodibenzo-p-dioxin (TCDD) inhibits neurite outgrowth in differentiating human SH-SY5Y neuroblastoma cells. Toxicol. Lett. 188: 153–156.
   PubMed Web of Science ®Google Scholar
• Kato TA, Matsuda T, Matsui S, Mizutani T, Saeki K (2002) Activation of the aryl hydrocarbon receptor by methyl yellow and related congeners: structure-activity relationships in halogenated derivatives. Biol. Pharm. Bull. 25: 466–471.
   PubMed Web of Science ®Google Scholar
• Kojima S, Kuo TF, Tatsukawa H (2012) Regulation of transglutaminase-mediated hepatic cell death in alcoholic steatohepatitis and non-alcoholic steatohepatitis. J. Gastroenterol. Hepatol. 27: 52–57.
   PubMed Web of Science ®Google Scholar
• Krig SR, Rice RH (2000) TCDD suppression of tissue transglutaminase stimulation by retinoids in malignant human keratinocytes. Toxicol. Sci. 56: 357–364.
   PubMed Web of Science ®Google Scholar
• Leblanc A, Day N, Menard A, Keillor JW (1999) Guinea pig liver transglutaminase: a modified purification procedure affording enzyme with superior activity in greater yield. Prot. Exp. Purif. 17: 89–95.
   PubMed Web of Science ®Google Scholar
• Liu LL, Gong LK, Qi XM, Cai Y, Wang H, Wu XF (2005) Altered expression of cytochrome P450 and possible correlation with preneoplastic changes in early stage of rat hepatocarcinogenesis. Acta Pharmacol. Sin. 26: 737–744.
   PubMed Web of Science ®Google Scholar
• Lotan R (1996) Retinoids in cancer chemoprevention. FASEB J. 10: 1031–1039.
   PubMed Web of Science ®Google Scholar
• Murugan RS, Uchida K, Hara Y, Nagini SD (2008) Black tea polyphenols modulate xenobiotic metabolizing enzymes, oxidative stress and adduct formation in a rat hepatocarcinogenesis model. Free Rad. Res. 42: 873–884.
   PubMed Web of Science ®Google Scholar
• Nebert DW, Roe AL, Dieter MZ, Solis WA, Yang Y, Dalton TP (2000) Role of the aromatic hydrocarbon receptor and [Ah] gene battery in the oxidative stress response, cell cycle control, and apoptosis. Biochem. Pharmacol. 59: 65–85.
   PubMed Web of Science ®Google Scholar
• Piacentini M, Fesus L, Sartori C, Ceru MP (1988) Retinoic acid-induced modulation of rat liver transglutaminase and total polyamines in vivo. Biochem. J. 253: 33–38.
   PubMed Web of Science ®Google Scholar
• Singh R, Kumar S, Rana AC, Sharma N (2012) Different models of hepatotoxicity and related liver diseases: a review. Int. Res. J. Pharm. 3: 86–95.
   Google Scholar
• Slezak BP, Diliberto JJ, Birnbaum LS (1999) 2,3,7,8-Tetrachlorodibenzo-p-dioxin-mediated oxidative stress in CYP1A2 knockout (CYP1A22/2) mice. Biochem. Biophys. Res. Commun. 264: 376–379.
   PubMed Web of Science ®Google Scholar
• Tirkey N, Kaur G, Vij G, Chopra K (2005) Curcumin, a diferuloylmethane, attenuates cyclosporine-induced renal dysfunction and oxidative stress in rat kidneys. BMC Pharmacol 5: 15.
   PubMedGoogle Scholar
• Wade MG, Foster WG, Younglai EV, McMahon A, Leingartner K, Yagminas A, Hughes CL (2002) Effects of subchronic exposure to a complex mixture of persistent contaminants in male rats: systemic, immune, and reproductive effects. Toxicol. Sci. 67: 131–143.
   PubMed Web of Science ®Google Scholar
• Walker NJ, Portier CJ, Lax SF, Crofts FG, Li Y, Lucier GW, Sutter TR (1999) Characterization of the dose response of CYP1B1, CYP1A1, and CYP1A2 in the liver of female Sprague-Dawley rats following chronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol. Appl. Pharmacol. 154: 279–286.
   PubMed Web of Science ®Google Scholar
• Whitlock JP Jr (1993) Mechanistic aspects of dioxin action. Chem. Res. Toxicol. 6: 754–763.
   PubMed Web of Science ®Google Scholar
• Wu J, Zern MA (2004) Tissue transglutaminase, a key enzyme involved in liver diseases. Hepatol. Res. 29: 1–8.
   PubMed Web of Science ®Google Scholar
• Yang YM, Huang DY, Liu GF, Zhong JC, Du K, Li YF, Song XH (2005) Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on vitamin A metabolism in mice. J. Biochem. Mol. Toxicol. 19: 327–335.
   PubMed Web of Science ®Google Scholar
• Zemskov EA, Janiak A, Hang J, Waghray A, Belkin AM (2006) The role of tissue transglutaminase in cell-matrix interactions. Front. Biosci. 11: 1057–1076.
   PubMed Web of Science ®Google Scholar